ARCHIVES

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

This article is from The Cancer Letter archive.

Vol. 25 No. 1 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Carter Transition Team Lists Prospects For HEW Secretary; Interferon Available

December 3, 1976

Money Earmarked for WVU Center Could Be Returned To Treasury; BYRD Get Assurances From DeVita

May 31, 1985

George Sledge Jr. Named Oncology Chief at Stanford University

October 12, 2012

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

Magnuson In Line For Appropriations Chairmanship

December 2, 1977

FDA Approvals: Cobas HPV Test Approved For Primary Cervical Screening

April 25, 2014